Surgical management of spinal osteoblastomas
Anne L. Versteeg,Nicolas Dea,Stefano Boriani,Peter Pal Varga,Alessandro Luzzati,Michael G. Fehlings,Mark H. Bilsky,Laurence D. Rhines,Jeremy J. Reynolds,Mark B. Dekutoski,Ziya L. Gokaslan,Niccole Germscheid,Charles G. Fisher +12 more
TL;DR: In this evaluation of the largest multicenter cohort of spinal osteoblastomas, local recurrence was found to be strongly associated with mortality and application of the Enneking classification as a treatment guide for preventing local Recurrence was not validated.
read more
Abstract: OBJECTIVE Osteoblastoma is a rare primary benign bone tumor with a predilection for the spinal column. Although of benign origin, osteoblastomas tend to behave more aggressively clinically than other benign tumors. Because of the low incidence of osteoblastomas, evidence-based treatment guidelines and high-quality research are lacking, which has resulted in inconsistent treatment. The goal of this study was to determine whether application of the Enneking classification in the management of spinal osteoblastomas influences local recurrence and survival time. METHODS A multicenter database of patients who underwent surgical intervention for spinal osteoblastoma was developed by the AOSpine Knowledge Forum Tumor. Patient data pertaining to demographics, diagnosis, treatment, cross-sectional survival, and local recurrence were collected. Patients in 2 cohorts, based on the Enneking classification of the tumor (Enneking appropriate [EA] and Enneking inappropriate [EI]), were analyzed. If the final pathology margin matched the Enneking-recommended surgical margin, the tumor was classified as EA; if not, it was classified as EI. RESULTS A total of 102 patients diagnosed with a spinal osteoblastoma were identified between November 1991 and June 2012. Twenty-nine patients were omitted from the analysis because of short follow-up time, incomplete survival data, or invalid staging, which left 73 patients for the final analysis. Thirteen (18%) patients suffered a local recurrence, and 6 (8%) patients died during the study period. Local recurrence was strongly associated with mortality (relative risk 9.2; p = 0.008). When adjusted for Enneking appropriateness, this result was not altered significantly. No significant differences were found between the EA and EI groups in regard to local recurrence and mortality. CONCLUSIONS In this evaluation of the largest multicenter cohort of spinal osteoblastomas, local recurrence was found to be strongly associated with mortality. Application of the Enneking classification as a treatment guide for preventing local recurrence was not validated.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Diagnostic and Management Options of Osteoblastoma in the Spine.
TL;DR: Accurate intraoperative localization with complete resection is the key to preventing recurrence and Aggressive surgical resection can achieve satisfactory clinical and radiographic outcomes.
Primary Benign Tumors of the Spinal Canal
01 Aug 2022
TL;DR: A review of extramedullary benign meningiomas, osteoid osteomas and osteoblastomas can be found in this paper , along with possible future targets that could lead to an improvement in their management.
17
Imaging algorithm and multimodality evaluation of spinal osteoblastoma.
Zihuan Huang,Tingsong Fang,Zhiguang Si,Youcai Li,Lan Zhang,Chunling Zheng,Shenmei Li,Manting Su,Xiaomin Liu,Xiaodan Li,Yuankui Wu +10 more
TL;DR: Although a larger sample size is needed, combining CT, MRI and PET may be beneficial to optimize preoperative diagnosis and care of patients with OBs.
Neoadjuvant denosumab for the treatment of a sacral osteoblastoma.
Jeremy J. Reynolds,Dominique A. Rothenfluh,Nicholas A. Athanasou,Shaun Wilson,David C. Kieser +4 more
TL;DR: A short course of denosumab caused tumour regression, ossification and conversion of an aggressive OB into a sclerotic, well-defined lesion thus aiding surgical resection and preservation of neural structures.
14
References
A system for the surgical staging of musculoskeletal sarcoma.
TL;DR: A surgical staging system for musculoskeletal sarcomas stratifies bone and soft-tissue lesions of any histogenesis by the grade of biologic aggressiveness, by the anatomic setting, and by the presence of metastasis, which permits appropriate evaluation and comparison of the new treatment protocols designed to replace standard surgical treatment.
2.3K
A system of staging musculoskeletal neoplasms.
TL;DR: A system for staging benign and malignant musculoskeletal lesions that articulates well with current radiologic techniques of staging and serves as a useful guide in the selection of an appropriate definitive surgical procedure.
1K
Chondrosarcoma of Bone: An Assessment of Outcome*
Francis Y. Lee,Henry J. Mankin,Gertrude Fondren,Mark C. Gebhardt,Dempsey S. Springfield,Dempsey S. Springfield,Andrew E. Rosenberg,L. Candace Jennings +7 more
TL;DR: Patients with a high-grade chondrosarcoma managed at one institution could not detect a significant difference in the rates of pulmonary metastasis and death between the patients who had a grade-3 lesion and those who hadA grade- 3 lesion that was also dedifferentiated.
435
Osteoblastoma: Clinicopathologic study of 306 cases
TL;DR: Aggressive behavior is within the biologic spectrum of osteoblastomas, and histopathology alone does not appear to be a reliable predictor of aggressiveness.
413
From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation.
Mark D. Murphey,C L Andrews,Donald J. Flemming,Donald J. Flemming,Donald J. Flemming,H T Temple,H T Temple,W S Smith,James G. Smirniotopoulos,James G. Smirniotopoulos +9 more
TL;DR: Radiologists should be aware of the appearance of these unusual neoplasms of the spine in order to provide a complete differential diagnosis and to guide clinical colleagues in patient treatment.
323